Viewing data from:

KURVELO

ANDA

ETHINYL ESTRADIOL; LEVONORGESTREL | A091408 | LUPIN LTD

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Kurvelo (2023)

Total Spending

$109K

Total Claims

3,772

Beneficiaries

935

Avg Cost/Unit

$0.47

Spending Trend

$95K(2019)→$107K(2020)→$103K(2021)→$89K(2022)→$109K(2023)

YoY Change:+4.7%

5yr CAGR:-1.1%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.03MG;0.15MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Oct 17, 2012

No patent or exclusivity listings for this strength.